Our Mission

Supporting innovators to fight drug-resistant infections

INCATE brings together translational and basic research, industry, experienced entrepreneurs and investors from across Europe to accelerate your innovation. We do this by providing advice, community and funding. Our focus is on the development of new therapies, and interventions that help reduce the prevalence and impact of Antimicrobial Resistance (AMR).

Our Vision

Bridge the gap!

Whats up?

Latest News

  • We are thrilled to announce a significant milestone for Invitris—a $650,000 deal plus royalties with the European market leader in technical aerosols! This achievement marks a major step forward for us, not only financially but [...]

What we do

Supporting your venture

Advice

Advice from partners, including Industry, to enable; early alignment with medical needs and market demand, the development of a quality translational path and a plan to build a company.

Community

Access to a community of engaged individuals across industry, academia, entrepreneurs, policymakers, investors, public health and healthcare providers to share ideas and fight drug-resistant bacterial infections together.

Funding

Up to €250,000 in non-dilutive funding  will be provided to selected projects to help answer critical questions needed to develop business and translational plans to convince investors at the next funding stage.

Why INCATE?

INCATE combines the know-how and resources of Academic Members, Industry and Supporting Partners to support your innovation.

INCATE Academic Members

INCATE Industry Partners

INCATE Supporting Partners

INCATE Media partners

GET MORE INFORMATION

Contact us!

Ina-Kristin Behrens, PhD

Active Scouting | Support of ventures

Mercedes Gonzalez, PhD

Active Scouting | Support of ventures